Skip to main content
. 2018 Oct 20;8(5):282–291.

Figure 3.

Figure 3

Binding of ZW800F-cRGD-DFO to HT-29 colorectal tumor cells. A: In vitro binding assay (median and range). B: In vivo binding of ZW800F-cRGD-Zr-DFO to the tumor (white arrow) and a peritoneal metastasis (dashed arrow) at 4 h after injection. NIRF imaging (Pearl) is in concordance with bioluminescence signals (IVIS).